REQUEST A DEMO
Total
USD $0.00
Search more companies

Riddhi Pharma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Riddhi Pharma S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Riddhi Pharma S A S is based in Colombia, with the head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on February 27, 2007. There are currently 23 (2024) people employed by Riddhi Pharma S A S. From the latest financial highlights, Riddhi Pharma S A S reported a net sales revenue increase of 61.66% in 2023. Its total assets grew by 27.5% over the same period. The net profit margin of Riddhi Pharma S A S increased by 0.73% in 2023.

Headquarters
Cra 69 B # 77 - 36
Bogota D.C.; Bogota D.C; Postal Code: 0904

Contact Details: Purchase the Riddhi Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Riddhi Pharma S A S report to view the information.
Outstanding Shares:
Purchase the Riddhi Pharma S A S report to view the information.
Incorporation Date:
February 27, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Riddhi Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
61.66%
Total operating revenue
61.66%
Operating profit (EBIT)
-17.82%
Net Profit (Loss) for the Period
319.67%
Total assets
27.5%
Total equity
3.74%
Operating Profit Margin (ROS)
-1.14%
Net Profit Margin
0.73%
Return on Equity (ROE)
2.71%
Quick Ratio
1.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?